GNFT - Genfit S.A.
Genfit S.A. Logo

GNFT - Genfit S.A.

https://www.genfit.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Genfit SA, a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company is headquartered in Loos, France.

52W High
$6.42
52W Low
$2.55
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.28
Valuation
Attractive
As of 2024-12-31 (Overview)
Trailing P/E (<15 better)
98.50
Forward P/E (<15 better)
7.27
EV/EBITDA (<8 favorable)
18.33
EV/Revenue (<3 favorable)
2.28
P/S (TTM) (<3 favorable)
2.80
P/B (<3 favorable)
2.44
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
0.00%
Institutions (25–75% balanced)
0.16%
Shares Outstanding
50,003,000
Float
43,768,200
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2024-12-31 (Overview)
Revenue (TTM)
70,692,000
Gross Profit (TTM)
70,692,000
EPS (TTM)
0.04
Profit Margin (>10% good)
0.02%
Operating Margin (TTM) (higher better)
-2.94%
ROE (TTM) (>15% strong)
0.02%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.51
Momentum
Bearish momentum
Value
0.0477
Previous
0.0333
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025